Tim Wilsdon is speaking during the session.
For more information on this event, click here.
Assessing the implications of centralized drug price setting to investment in clinical development for HIV treatments
The Build Back Better Act, which is under consideration for passage into law includes price controls in Medicare Part B and D and price caps more broadly. In...